Knowledge Transfer in the Post-Genome World: keeping up is not good enough Timothy D. Smith.

Slides:



Advertisements
Similar presentations
I. high-fat, adequate-protein, low-carbohydrate diet. II. The diet forces the body to burn fats rather than carbohydrates. III. The original therapeutic.
Advertisements

Regulation of food intake. Food intake Regulation –Endocrine Adipose tissue Pancreas Liver Muscle –CNS.
MODY: MATURITY-ONSET DIABETES OF THE YOUNG Stefan S. Fajans, MD University of Michigan May 2004.
HISTORY OF MONOGENIC DIABETES Graeme Bell Advances in Monogenic Diabetes Care and Research Chicago, IL Saturday, July 20, 2013.
By Deborah Taylor.  A hormone  Produced in the pancreas by the beta cells of the Islets of Langerhans  Released when sugars are in the stomach  It’s.
Diabetes mellitus Dr. Essam H. Jiffri.
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
Low birth weight Zahra N. Sohani Supervisor: Dr. Sonia Anand.
Insulin Receptor. Pancreas is the endocrine organ that produces and releases insulin.
Interactions between the Liver and Pancreas. Explain the control of blood glucose concentration, including the roles of glucagon, insulin and α and β.
Endocrine System continued.
Note No cow’s milk or cow’s milk products (including but not limited to cheese and yoghurt) under the age of one year -casein (a protein in cow’s milk)
Chapter 13 Disorders of the Pancreas
BC21D Carbohydrate Metabolism Rachael Irving Biochemistry.
Biotechnology pp WHAT IS IT?  Biotechnology : the application of technology to better use DNA and biology.
Explain the control of blood glucose concentration, including the roles of glucagon, insulin, and a and B in the pancreatic islets Pancreas: exocrine.
Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.
Pancreas – Disorders Biology Pancreas The pancreas is between the kidneys and the duodenum and provides digestive juices and endocrine functions.
The genetic bases BY Casey Jaroche
Responses of Cells to Environmental Influences By Kari Edge.
Diabetes Mellitus Type 1 By: Jennifer Marks. What is it… Also known as juvenile diabetes, or juvenile- onset diabetes It’s an autoimmune disease that.
Role of CTLA-4 polymorphism in susceptibility to type 1 diabetes: Results of a family and a case-control study in Southern Tunisia Immunology Department,
Cell to Cell Communication: Diabetes and Insulin By: Fayth Kakos, Amy Klezek, and Charlotte Pierce.
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Carbohydrates: Clinical applications Carbohydrate metabolism disorders include: Hyperglycemia: increased blood glucose Hypoglycemia: decreased blood glucose.
Glucokinase, a glucose sensor Allison Craney November 30, 2006.
How are Genes Regulated? DNA is present in (almost) all cells. – An exception: RBC Do all genes need to be transcribed into mRNA at the same time in each.
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells  Takahisa Fujikawa, Seh-Hoon.
Stages in the development of type 2 DM from a pre-diabetic, insulin-resistant state. As insulin sensitivity decreases, insulin-mediated glucose disposal.
Figure 1 Body weight of control and BPA-treated mothers after delivery
Mean rates of insulin and glucagon delivery from an artificial pancreas at various blood glucose levels. The device was programmed to establish and maintain.
Identifying monogenic diabetes
The Pancreas.
Nat. Rev. Endocrinol. doi: /nrendo
Rashmi B. Prasad, Leif Groop  Cell Metabolism 
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
Pedigrees of the families of patients 1 and 2 show that the clinical phenotype co-segregates with compound heterozygous CLDN10 variants. Pedigrees of the.
Safia Costes, Peter C. Butler  Cell Metabolism 
Transcriptional Noise and Somatic Mutations in the Aging Pancreas
Diabetes Mellitus and the β Cell: The Last Ten Years
Chapter 29 Genetics and Diabetes
The Emerging Genetic Architecture of Type 2 Diabetes
Amélie Bonnefond, Philippe Froguel  Cell Metabolism 
Figure 1 Large consanguineous pedigree from Northern Pakistan
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Novel Transglutaminase 1 Gene Mutations (R348X/Y365D) in a Japanese Family with Lamellar Ichthyosis  Atsushi Kon, MD, PhD, Hitoshi Takeda, Hideyuki Sasaki,
Anna B. Osipovich, Mark A. Magnuson  Cell Stem Cell 
Effect of insulin on hepcidin expression in HepG2 cells.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 4 Gene disruption via chip.
ENDOCRINE SYSTEM pp
Immune cell activation detected by gene expression in representative pancreatic islets of IDDM rats after successful combination therapy with anti–TNF-α.
IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.
Grg3 works with Pdx1 to repress α-cell genes and induce glucose-stimulated insulin secretion. Grg3 works with Pdx1 to repress α-cell genes and induce glucose-stimulated.
Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,
Grg3 is expressed in most β-cells but less frequently in α-cells.
A-N: Immunofluorescence analysis of Bcl family genes in human islets of Langerhans. A-N: Immunofluorescence analysis of Bcl family genes in human islets.
Impaired in vitro adipogenic differentiation parallels elevated HDAC9 expression. Impaired in vitro adipogenic differentiation parallels elevated HDAC9.
GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.
Chop deletion preserves β-cell function in P58IPK−/− mice.
Npas4 is a stress-induced factor in pancreatic β-cells.
Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,
Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.
Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in.
Partial pedigrees for novel INS mutations identified in probands with MODY and young type 2 diabetes. Partial pedigrees for novel INS mutations identified.
RBP4 and glucose metabolism.
Mean changes (standard error) from baseline in A1C (A and B) and body weight (C and D) for patients with type 1 (A and C) or type 2 (B and D) diabetes.
Fig. 3 Genome editing of the MSTN gene.
Presentation transcript:

Knowledge Transfer in the Post-Genome World: keeping up is not good enough Timothy D. Smith

Rebholz-Schuhmann et al. 2005

Jensen et al. 2006

We analysed the TGM2 gene in 205 patients with clinically defined Maturity Onset Diabetes of the Young (MODY) or early-onset type 2 diabetes. We found two novel heterozygous mutations (c.989T>G, p.M330R; c.992T>A, p.I331N), which were not detected in 300 normoglycemic controls. All mutations were in residues which are located close to the catalytic site and impaired transamidating activity in vitro. Gene expression of TGM family genes and localization of TG2 in normal human pancreas indicated that TG2 is the only transglutaminase significantly expressed in human pancreatic islet cells. We conclude that reduced TG2 activity can contribute to disorders of glucose metabolism possibly via an impairment of insulin secretion. Porzio et al. 2007

SPECIEShuman GENE NAMETGM2 ACCESSIONNM_ VARIANTc.989T>G BASE CHANGE TYPESubstitution PROTEIN EFFECT- PHENOTYPEImpaired enzyme activity; glucose metabolism disorder

CDC28 Cyclin-dependant kinase 1 Cdk1

hairy

white

T98G L23A

The mutation in exon 7 c.989T>G (p.M330R), was found in a Danish patient (D79) with early onset type 2 diabetes. Porzio et al. 2007

c.989T>G

TGM2:c.989T>G

...the substitution of a nucelotide at position 989 to guanine...

A second heterozygous mutation in exon 7 c.992T>A (p.I331N) was identified in a French family (F193, Fig. 1B). The mutation was detected in the index case (Fig. 1B, II-2), who presented with diabetes at the age of 39 (therapy: diet) and in two diabetic siblings (II-4, II-6, treated with diet and OHA, respectively).

Solutions

Better tools Standards Access Copyright Format Mark-up Structured Digital Abstract (Seringhaus & Gerstein 2007)

Knowledge Transfer in the Post-Genome World: keeping up is not good enough Timothy D. Smith